熱門資訊> 正文
PAVmed获得180天的延期以恢复纳斯达克上市合规
2025-07-30 20:16
- PAVmed (NASDAQ:PAVM) has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under the Nasdaq listing rule.
- The company now has until January 19, 2026 to meet the requirement.
- Source: Press Release
More on PAVmed, Lucid Diagnostics
- PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript
- Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript
- Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
- Lucid says meeting scheduled to determine Medicare coverage for cancer test
- Seeking Alpha’s Quant Rating on PAVmed
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
